Abstract
Depression is a common comorbidity in patients suffering from functional illnesses. When compared with the general population, the prevalence of depression is higher in patients with functional symptoms. In fact, from a biopsychosocial perspective, depressive symptoms and affective dysregulation could be considered predisposing, precipitating, and perpetuating factors. Affective disorders in functional illness impact patients’ quality of life and overall prognosis. In this chapter, the prevalence of affective symptoms in patients with functional illnesses will be discussed. Furthermore, the role of depression as a risk factor as well as its impact on prognosis and recovery will be detailed. Finally, different treatment modalities for the management of depression in functional illnesses will be outlined.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
O'Neal MA, Baslet G. Treatment for patients with a functional neurological disorder (conversion disorder): an integrated approach. Am J Psychiatry. 2018;175(4):307–14.
Baslet G, Bajestan SN, Aybek S, Modirrousta M, Price JD, Cavanna A, et al. Evidence-based practice for the clinical assessment of psychogenic nonepileptic seizures: a report from the American neuropsychiatric association committee on research. J Neuropsychiatry Clin Neurosci. 2021;33(1):27–42.
Gracely RH, Ceko M, Bushnell MC. Fibromyalgia and depression. Pain Res Treat. 2012;2012:486590.
Perez DL, Aybek S, Popkirox S, Kozlowska K, Stephen CD, Anderson J, et al. A review and expert opinion on the neuropsychiatric assessment of motor functional neurological disorders. J Neuropsychiatry Clin Neurosci. 2021. Winter;33(1):14–26.
Fuller-Thomson E, Nimigon-Young J, Brennenstuhl S. Individuals with fibromyalgia and depression: findings from a nationally representative Canadian survey. Rheumatol Int. 2012;32(4):853–62.
Alciati A, Atzeni F, Caldirola D, Perna G, Sarzi-Puttini P. The co-morbidity between bipolar and panic disorder in fibromyalgia syndrome. J Clin Med. 2020;9(11):3619.
Willinger U, Völkl-Kernstock S, Aschauer HN. Marked depression and anxiety in patients with functional dysphonia. Psychiatry Res. 2005;134(1):85–91.
Ricciardi L, Demartini B, Morgante F, Parees I, Nielsen G, Edwards MJ. Symptom severity in patients with functional motor symptoms: patient’s perception and doctor’s clinical assessment. Parkinsonism Relat Disord. 2015;21(5):529–32.
Lotrich FE, Pollock BG. Meta-analysis of serotonin transporter polymorphisms and affective disorders. Psychiatr Genet. 2004;14(3):121–9.
Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum. 2002;46(3):845–7.
Raphael KG, Janal MN, Nayak S, Schwartz JE, Gallagher RM. Familial aggregation of depression in fibromyalgia: a community-based test of alternate hypotheses. Pain. 2004;110(1-2):449–60.
Gold PW, Gabry KE, Yasuda MR, Chrousos GP. Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin N Am. 2002;31(1):37–62. vi
Fitzcharles MA, Ste-Marie PA, Goldenberg DL, Pereira JX, Abbey S, Choinière M, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119–26.
Pick S, Goldstein LH, Perez DL, Nicholson TR. Emotional processing in functional neurological disorder: a review, biopsychosocial model and research agenda. J Neurol Neurosurg Psychiatry. 2019;90(6):704–11.
Pun P, Frater J, Broughton M, Dob R, Lehn A. Psychological profiles and clinical clusters of patients diagnosed with functional neurological disorder. Front Neurol. 2020;11:580267.
Ritchey M, Dolcos F, Eddington KM, Strauman TJ, Cabeza R. Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. J Psychiatr Res. 2011;45(5):577–87.
Baker J. Women's voices: lost or mislaid, stolen or strayed? Int J Speech Lang Pathol. 2010;12(2):94–106.
Deary V, Miller T. Reconsidering the role of psychosocial factors in functional dysphonia. Curr Opin Otolaryngol Head Neck Surg. 2011;19(3):150–4.
Thomas M, Vuong KD, Jankovic J. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord. 2006;12(6):382–7.
Crimlisk HL, Bhatia K, Cope H, David A, Marsden CD, Ron MA. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ. 1998;316(7131):582–6.
Jalilianhasanpour R, Ospina JP, Williams B, Mello J, MacLean J, Ranford J, et al. Secure attachment and depression predict 6-month outcome in motor functional neurological disorders: a prospective pilot study. Psychosomatics. 2019;60(4):365–75.
Ibrahim NM, Martino D, van de Warrenburg BP, Quinn NP, Bhatia KP, Brown RJ, et al. The prognosis of fixed dystonia: a follow-up study. Parkinsonism Relat Disord. 2009;15(8):592–7.
Feinstein A, Stergiopoulos V, Fine J, Lan AE. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol. Behav Neurol. 2001;14(3):169–76.
Gilmour GS, Nielsen G, Teodoro T, Yogarajah M, Coebergh JA, Dilley MD, et al. Management of functional neurological disorder. J Neurol. 2020;267(7):2164–72.
Adams C, Anderson J, Madva EN, LaFrance WC Jr, Perez DL. You've made the diagnosis of functional neurological disorder: now what? Pract Neurol. 2018;18(4):323–30.
Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry. 2005;66(12):1529–34.
Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014;11:CD010628.
Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55.
Mudyanadzo TA, Hauzaree C, Yerokhina O, Architha NN, Ashqar HM. Irritable bowel syndrome and depression: a shared pathogenesis. Cureus. 2018;10(8):e3178.
Wilmes L, Collins JM, O'Riordan KJ, O'Mahony SM, Cryan JF, Clarke G. Of bowels, brain and behavior: a role for the gut microbiota in psychiatric comorbidities in irritable bowel syndrome. Neurogastroenterol Motil. 2021;33(3):e14095.
Marangell LB, Clauw DJ, Choy E, Wang F, Shoemaker S, Bradley L, et al. Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. Pain. 2011;152(1):31–7.
Cuijpers P, Quero S, Dowrick C, Arroll B. Psychological treatment of depression in primary care: recent developments. Curr Psychiatry Rep. 2019;21(12):129.
Cuijpers P, Karyotaki E, Eckshtain D, Ng MY, Corteselli KA, Noma H, et al. Psychotherapy for depression across different age groups: a systematic review and meta-analysis. JAMA Psychiat. 2020;77(7):694–702.
Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord. 2014;20(1):60–3.
Baslet G, Dworetzky B, Perez DL, Oser M. Treatment of psychogenic nonepileptic seizures: updated review and findings from a mindfulness-based intervention case series. Clin EEG Neurosci. 2015;46(1):54–64.
Zaroff CM, Myers L, Barr WB, Luciano D, Devinsky O. Group psychoeducation as treatment for psychological nonepileptic seizures. Epilepsy Behav. 2004;5(4):587–92.
Vasile C. CBT and medication in depression (review). Exp Ther Med. 2020;20(4):3513–6.
Gautam M, Tripathi A, Deshmukh D, Gaur M. Cognitive behavioral therapy for depression. Indian J Psychiatry. 2020;62(Suppl 2):S223–9.
LaFrance WC Jr, Baird GL, Barry JJ, Blum AS, Frank Webb A, Keitner GI, et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures. JAMA Psychiat. 2014;71:997–1005.
Hou WH, Wang TY, Kang JH. The effects of add-on non-invasive brain stimulation in fibromyalgia: a meta-analysis and meta-regression of randomized controlled trials. Rheumatology (Oxford). 2016;55(8):1507–17.
Peterson KT, Kosior R, Meek BP, Ng M, Perez DL, Modirrousta M. Right temporoparietal junction transcranial magnetic stimulation in the treatment of psychogenic nonepileptic seizures: a case series. Psychosomatics. 2018;59(6):601–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Modirrousta, M. (2023). Depression. In: Blakley, B.W., Blakley, J.E. (eds) Functional Illness of the Head and Neck. Springer, Cham. https://doi.org/10.1007/978-3-031-12998-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-031-12998-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-12997-1
Online ISBN: 978-3-031-12998-8
eBook Packages: MedicineMedicine (R0)